← Insider buys
OCGN

Ocugen, Inc. · Healthcare

CEO Shankar Musunuri sold $337K of Ocugen, Inc.

Sold$336,600
$3.74Price
90,000Shares
−5%Stake

What OCGN did after the filing

Filed Feb 16, copier in the same day
The stock from Wed, Feb 16 close, $3.82
−13.6%
S&P 500, same days
+1.4%

Measured over 30 trading days, to the Mar 31 close.

Traded Mon, Feb 14. Filed Wed, Feb 16, 11:03 AM ET, during the session. Returns use the Feb 16 close and the Mar 31 close. Not investment advice.